Muscle weakness causes joint degeneration in rabbits  by Rehan Youssef, A. et al.
Osteoarthritis and Cartilage (2009) 17, 1228e1235





SocietyMuscle weakness causes joint degeneration in rabbits
A. Rehan Youssefy, D. Longinoz, R. Seerattany, T. Leonardy and W. Herzogy*
yHuman Performance Laboratory, Faculty of Kinesiology, University of Calgary, AB, Canada
zSport Medicine Centre, Faculty of Kinesiology, University of Calgary, AB, Canada
Summary
Objective: The objective of this study was to investigate the effects of botulinum toxin type-A (BTX-A) induced quadriceps weakness on micro-
structural changes in knee cartilage of New Zealand White (NZW) rabbits.
Design: Fifteen rabbits were divided randomly into an experimental and a sham control group. Each group received a unilateral single quad-
riceps muscle injection either with saline (sham control; n¼ 4) or BTX-A (experimental; n¼ 11).
Results: BTX-A injection produced signiﬁcant quadriceps muscle weakness (P< 0.05) and loss of quadriceps muscle mass (P< 0.05). De-
generative changes of the knee cartilage, assessed with the Mankin grading system, were the same for the injected and non-injected hind
limbs of the experimental group animals. Sham injection had no effect on joint degeneration but all control animals showed some degenerative
changes in the knee. Degenerative changes of the retro-patellar cartilage were more severe in the experimental compared to sham control
group rabbits (P< 0.05). The distal region of the retro-patellar cartilage was more degenerated than the proximal part in the experimental
and control group rabbits (P< 0.05). The Mankin grades for the tibiofemoral region were not signiﬁcantly different between experimental
and control group rabbits (P> 0.05).
Conclusion: Quadriceps muscle weakness caused increased degeneration in the retro-patellar cartilage of NZW rabbits, providing evidence
that muscle weakness might be a risk factor for the onset and progression of osteoarthritis (OA). Future work needs to delineate whether mus-
cle weakness directly affects joint degeneration, or if changes in function and movement execution associated with muscle weakness are re-
sponsible for the increased rate of OA onset and progression observed here.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is one of the most prevalent chronic
musculoskeletal disorders in Canada. It affects approxi-
mately 10% of the adult Canadian population1,2. It causes
pain and disability and is associated with a substantial
economic burden and serious socioeconomic
consequences3e6.
The etiology of OA is thought to be multi-factorial and
pathological changes may take place in different tissues
of joints. OA studies have mainly focused on the changes
occurring following intra-articular derangement such as lig-
ament transection7 or meniscectomy8. Little is known on
how changes in periarticular structures, such as skeletal
muscles, may affect the fully intact joint.
Muscles and joints are functionally interdependent, as
muscles move the joints, contribute to joint stability9, and
provide shock absorption10,11. Muscles are also the biggest
contributors to the mechanical loading of joints which is
thought to provide crucial mechanical stimuli for joint integ-
rity and cartilage nutrition12,13. Muscles are also implicated
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1228and sensory functions of muscles are integrated to generate
a neuromuscular protective mechanism that allows safe,
smooth, functional movements15,16.
Muscle weakness is an acknowledged associate of joint
degeneration and OA, and previous studies have provided
evidence that muscle weakness might be an independent
contributor to the initiation and development of OA. Muscle
weakness is one of the earliest symptoms in patients with
OA17,18. Also, OA has been associated with reduced mus-
cle strength, decreased activation, and abnormal contrac-
tion patterns17e23. Moreover, major causes of OA, such
as joint injuries, aging and obesity, are accompanied by
a loss of muscle mass, strength and ﬁne movement control
making joints more susceptible to fatigue24e27.
Muscle weakness was found to be a better predictor of
joint disability and OA6,23,26,28 than radiographic assess-
ment29. These ﬁndings suggest that impaired sensorimotor
function plays a signiﬁcant role in the development and pro-
gression of OA15,16,30,31. However, the possible role of mus-
cle weakness in the development and progression of joint
degeneration leading to OA remains unclear. Herzog and
Longino32 developed a quadriceps weakness model in the
New Zealand White (NZW) rabbit and found evidence of ar-
ticular cartilage reddening which was interpreted as an early
sign of cartilage deterioration. However, no histological as-
sessment of the joint surfaces or molecular biology ap-
proaches of the cartilage were performed to strengthen
the ‘‘clinical’’ observation. Therefore, the purpose of this
1229Osteoarthritis and Cartilage Vol. 17, No. 9study was to investigate the histopathological changes in
the rabbit knee following a period of systematic knee exten-
sor weakness. We hypothesized that muscle weakness is
associated with degenerative changes in the knee cartilage,
thereby providing evidence that muscle weakness might be
an independent risk factor for joint degeneration leading to
OA.
MethodsEXPERIMENTAL DESIGNFifteen skeletally mature, 1-year-old, female NZW rabbits (4.75e5.75 kg,
Riemens, St. Agatha, Ont., Canada) were obtained and studied with the ap-
proval of the Animal Care Committee of the University of Calgary. All animals
were housed locally in accordance with the Canadian Council on Animal
Care Guidelines. Rabbits received a standard diet and water ad libitum
and were allowed normal activity in individual cages (65 45 30 cm).
The animals were divided randomly into two groups:
(1) Sham controls: 4 weeks post saline injection (n¼ 4).
(2) Experimental rabbits: 4 weeks post single botulinum toxin type-A
(BTX-A) injection (n¼ 11).INJECTION PROTOCOLThe BTX-A group received a one-time intramuscular BTX-A injection into
the quadriceps muscle. The total dose given to each animal was 3.5 units/kg.
A 100 unit vial of vacuum-dried C. botulinum type-A neurotoxin complex (Bo-
tox, Allergan, Inc., Toronto, Ontario, Canada) was reconstituted with a 0.9%
sodium chloride (without preservatives) to a concentration of 20 units/ml.
Prior to the injection, the rabbits were sedated with a 0.18 ml subcutaneous
injection of Atravet (10 mg/ml) (Acepromazine, Ayerst Laboratories, Mon-
treal, Quebec, Canada). Then, general anesthesia was induced and main-
tained using a blend of oxygen, nitrous oxide and 1% isoﬂurane. BTX-A
injections were given, at random, either to the right or left quadriceps, as de-
scribed earlier33,34. Brieﬂy, the anterior compartment of the thigh, containing
the quadriceps muscle, was isolated by manual palpation. Then the quadri-
ceps was divided visually into superior and inferior halves. Each half was fur-
ther divided into medial, central and lateral sections. One-sixth of the total
BTX-A dose was injected into each of the six sections using a 30-gauge
needle.
The sham control animals received injections of a 0.9% sodium chloride
solution using an identical procedure and an equal injection volume as that
used for the experimental animals. Experimental and control animals were
then left alone for 4 weeks, when the outcome measures were determined.Fig. 1. Torques recorded from the quadriceps muscles of an experimenta
knee angles (75, 100, 125). There is a clear and distinct decrease in mu
limb. Tw¼ twitch contraction, 10, 50, 100 and 200 refer to 10, 50, 100 an
innervates the quadrOutcome measuresISOMETRIC KNEE EXTENSOR TORQUEFor the experimental and control group rabbits, muscle
weakness was calculated as the percentage difference in
knee extensor torque between the injected and contra-lat-
eral non-injected hind limbs. Knee extensor torques were
obtained by electrical stimulation of the knee extensor mus-
cles using bilateral femoral nerve cuff stimulators that were
implanted immediately prior to testing, as described
earlier33,34.
Knee joints were ﬁxed with two stainless steel bone pins
(5 mm diameter) with sharpened tips. The bone pins were
inserted from either side into the lateral and medial femoral
condyles, respectively. These pins were then clamped to
a stereotaxic frame speciﬁcally designed for rabbit knee
joint testing.
Torques were measured with a tibial restraining bar made
of stainless steel and implemented with strain gauges at the
distal end that were conﬁgured in a Wheatstone bridge con-
ﬁguration33,34. The strain gauges in this system can distin-
guish forces of 0.1 N and the frequency response is 60 Hz
which is sufﬁcient for the isometric measurements
performed here.
Calibration of the tibial restraining bar was made by ap-
plying 10 known forces to the bar and measuring the corre-
sponding voltage output. Linear regression analysis
revealed values of r> 0.999 between voltage and applied
force for the relevant measurement range.
Maximum isometric knee extensor torques were recorded
from each hind limb for knee angles of 75, 100, and 125
using single twitches and 0.5 s contractions with stimulation
frequencies of 10, 50, 100, and 200 Hz (Fig. 1). Torque
measurements were repeated for the twitch and 100 Hz
contractions at the start and end of each series of tests at
a given knee angle to assess fatigue. All measurements
were done by an independent tester who was blinded to
the side of BTX-A or saline injection and the grouping of
the rabbits (experimental and control).l rabbit (BTX-A injected and its contra-lateral side) at three different
scle torque in the Botox injected compared to the contra-lateral hind
d 200 pulses of stimulation per second of the femoral nerve which
iceps muscles.
Table I
Standard Mankin grading system35
I. Structure
a. Normal 0
1230 A. Rehan Youssef et al.: Weakness causes joint degenerationAll measurements (including the repeat tests at 100 Hz
and the single twitches) were used for analysis. Torque
reported represents the percent difference between hind
limbs.b. Surface irregularities 1
c. Pannus and surface irregularities 2
d. Clefts to transitional zone 3QUADRICEPS MUSCLE MASSe. Clefts to radial zone 4
f. Clefts to calciﬁed zone 5
g. Complete disorganization 6
II. Cells
a. Normal 0
b. Diffuse hypercellularity 1
c. Cloning 2
d. Hypocellularity 3
III. Safranin-O stainingImmediately following the knee extensor testing, rabbits
were sacriﬁced by a lethal dose of Euthanyl (Pentobarbital
sodium injection; Biomeda-MTC pharmaceuticals, Cam-
bridge, Ontario) into the lateral ear vein. The rectus femoris,
vastus medialis and vastus lateralis (VL) muscles from both
hind limbs were harvested and their wet masses were de-
termined using a laboratory scale with an accuracy of
0.001 g. Differences in muscle mass are reported as the
percent differences between corresponding hind limbs.a. Normal 0
b. Slight reduction 1
c. Moderate reduction 2
d. Severe reduction 3HISTOLOGY ANALYSIS
e. No dye noted 4
IV. Tidemark integrity
a. Intact 0
b. Crossed by blood vessels 1The OA grade for the knee cartilage was the main out-
come measure of our study. For this purpose, the Mankin
OA grading system was used35.
After sacriﬁce, knee joints were dissected, excess mus-
cles were trimmed away, and joints were ﬁxed in a 10% neu-
tral buffered formalin solution (Fisher Scientiﬁc) for 10 days at
room temperature. Following formalin ﬁxation, the joints were
transferred to a Cal-Ex II decalcifying solution (10% formic
acid solution in formaldehyde, Fisher Scientiﬁc) and kept at
room temperature. The solution was changed daily. After 2
weeks, the joints were cut opened and returned to a fresh de-
calcifying solution for an additional 2e3 weeks. Decalciﬁca-
tion was ﬁnished when joints could be cut smoothly and
without any grittiness. The joints were then washed thor-
oughly in running tap water for 2 h. Then, they were pro-
cessed in an automatic parafﬁn processor (Leica TP 1020)
where they were dehydrated in a graded series of alcohols
ranging between 80% and 100%, cleared in xylene and inﬁl-
trated in amixed Paraplast-plus/extra wax (Fisher Scientiﬁc).
The individual bones of the knee (tibia, femur and patella)
were then embedded in parafﬁn molds and stored at room
temperature until they were sectioned.
Serial sections of the knee articular cartilage were cut at
12e15 mm thickness using a Leica RM 2165 microtome.
Every third section was collected, adhered to Superfrost
Plus slides (Fisher Scientiﬁc) and allowed to dry at 40C
for 7 days. Alternate slides were then stained with hematox-
ylin, Safranin-O, and fast green (Fisher Scientiﬁc). Sections
were then dehydrated in ethanol, cleared in xylene, and ﬁ-
nally cover-slipped with Polymount mounting media (Fisher
Scientiﬁc) before they were allowed to dry at room temper-
ature for several days.
Sections were viewed on a light microscope (Zeiss Axio-
star plus) by two examiners who were blinded to the study
design. Examinations were made with a 25 objective for
cartilage scoring and a 200 objective to conﬁrm cellular
changes. Sections were examined according to the Mankin
criteria (Table I)35. Scores of the patellae from the two ex-
aminers were used to establish the interobserver reliability.
The standard Mankin system assesses surface structure,
cellularity, matrix staining and tidemark integrity of the most se-
vere lesion present. The overall Mankin grade ranges between
0 (normal) and 14 (severeOA)35. For each joint, the section that
showed themost severe OA changes in each of the knee carti-
lage regionswasgraded.For the retro-patellarcartilage, surface
was divided visually into three thirds (proximal, middle and dis-
tal) using a micrometer eyepiece reticule (area¼ 12.5 12.5;divided in ﬁeld of 10 10, Zeiss). For each patella, each region
was assigned a grade, and the worst of all grades was used as
the worst retro-patellar Mankin grade.STATISTICAL ANALYSISDue to the small number of independent observations,
non-parametric statistical analysis was used. For the iso-
metric knee extensor torque and muscle mass, outcomes
were reported as relative percent deﬁcits of the experimen-
tal compared to the sham control group rabbits. Compari-
sons within each of the two study groups were done using
the Friedman test followed by the Wilcoxon signed ranks
test to determine which variable was signiﬁcantly different.
Comparisons between the experimental and the control
groups were done using the KruskaleWallis test followed
by the ManneWhitney U test to determine the variable
that is different. Spearman’s rho correlation coefﬁcient
was calculated using the two examiner’s scores of the
patellar cartilage. The level of signiﬁcance was set at
a¼ 0.05 throughout. All statistical tests were done using
SPSS 14 (SPSS Inc., Chicago, Illinois, USA).Results
Body weight at the start and end of the study was the same
for the experimental and control group rabbits. Surgery and
injections were well tolerated by all animals. None of the ex-
perimental animals showed any signs of toxin overdose,
such as ptosis or increased respiratory distress.ISOMETRIC KNEE EXTENSOR TORQUEThe BTX-A group had a signiﬁcantly greater (P< 0.05)
torque deﬁcit [%] than the control group (Fig. 2). In the ex-
perimental rabbits, the average muscle weakness across
all knee angles and stimulation frequencies was 80%
(10%). In the control rabbits, there was no difference in
average strength (9% 15%) between hind limbs.
Fig. 2. Percent weakness reﬂects the relative decrease in torque
between corresponding hind limbs in the experimental and the
sham control rabbits, averaged across all knee angles and stimula-
tion frequencies tested. Group mean and standard deviation (SD)
are shown. The experimental group had a signiﬁcantly greater
weakness [%] than the control group (*P< 0.05).
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Fig. 4. Example of the VL muscle taken from an experimental
BTX-A injected hind limb (Left), and its contra-lateral non-injected
side (right). Note the atrophy seen in the BTX-A injected compared
to the non-injected contra-lateral side.Total quadriceps muscle mass deﬁcits were signiﬁcantly
higher (P< 0.05) in the BTX-A rabbits (37 7%) compared
to the controls (2 9%) (Figs. 3 and 4).MANKIN GRADESThe knee cartilage from the experimental BTX-A injected
(n¼ 11) and control rabbits (n¼ 4) was graded using the
Mankin grading system35.
The Mankin grades of the control rabbits (n¼ 4) were the
same for the injected and non-injected hind limbs (Table II).
Since muscle weakness was statistically the same between
the injected and non-injected hind limbs of the controlFig. 3. Percent mass deﬁcit reﬂects the relative decrease in total
quadriceps muscle mass between the corresponding hind limbs
in the experimental compared to the sham control rabbits. Group
means and SD are shown. The experimental group had a signiﬁ-
cantly greater total quadriceps muscle mass deﬁcit [%] compared
to the control group (*P< 0.05).rabbits (P> 0.05), OA grades from both hind limbs in the
control group were pooled (n¼ 8) and the Mankin grades
of the control group rabbits were compared to those of the
injected (n¼ 11) and non-injected (n¼ 11) hind limbs of
the experimental group rabbits.
The worst Mankin grades for the entire patella were signif-
icantly higher for the experimental compared to the control
group rabbits (P< 0.05). Also, Mankin grades for the distal
1/3 of the patella were signiﬁcantly higher in the experimental
compared to the control group (P< 0.05).Within each group,
there was a location-dependent distribution of the degenera-
tive changes with the proximal 1/3 of the patella showing the
least degeneration and the distal 1/3 showing the most de-
generation. Speciﬁcally for the BTX-A injected limbs, the dis-
tal 1/3 of the retro-patellar surface was signiﬁcantly more
degenerated than the middle and proximal regions
(P< 0.05). For the control group rabbits, the proximal 1/3
showed signiﬁcantly lower Mankin grades compared to the
rest of the patella (P < 0.05) (Figs. 5 and 6).
Mankin scores for the entire tibiofemoral joint and for the
individual regions of the joint (medial tibia, medial femur, lat-
eral tibia, and lateral femur) were not signiﬁcantly different
(P> 0.05) between control and experimental group rabbits
(Table II).Discussion
The results of this study provide evidence that quadriceps
weakness promotes OA progression in the retro-patellar
cartilage of NZW rabbits but not in the tibiofemoral cartilage.
Interestingly, the degenerative changes between injected
(sham or BTX-A) and non-injected hind limbs of the control
and the experimental group rabbits were statistically the
Table II
Mankin grades of the injected and non-injected hind limbs of the experimental and control rabbits. Median and SD of the medial femur, medial
tibia, lateral femur, lateral tibia, the retro-patellar cartilage and the worst grade of the knee joint are shown. There were no significant differ-
ences in OA grades between hind limbs within each of the two groups
Group Hind limb Medial femur Medial tibia Lateral femur Lateral tibia Patella Worst grade
Experimental Injected 4.0 (4.4) 6.0 (3.6) 0.0 (3.3) 0.0 (1.2) 7.0 (1.4) 9.0 (1.7)
Non-injected 8.0 (4.3) 7.0 (2.9) 0.0 (2.1) 0.0 (1.8) 8.0 (2.0) 9.0 (2.0)
Control Injected 3.0 (4.9) 7.0 (3.5) 3.5 (4.4) 0.0 (2.5) 5.0 (2.1) 7.5 (1.4)
Non-injected 1.5 (3.2) 0.0 (3.5) 0.0 (4.5) 1.5 (5.2) 4.0 (3.0) 8.0 (3.4)
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animals showed signiﬁcantly higher Mankin scores in
the retro-patellar surface region than the control group
rabbits. There were location-dependent changes in the
retro-patellar cartilage of experimental and control group
animals. The proximal regions of the retro-patellar surface
always showed less degenerative signs than the distal re-
gions. There were no differences in Mankin scores for any
of the regions of the tibiofemoral joint between experimental
and control group rabbits.
The higher retro-patellar Mankin scores for the experi-
mental compared to the control group rabbits may be attrib-
uted to muscle weakness which interferes with normal
loading of the knee. It is known that muscles stabilize joints
and contribute signiﬁcantly to their loading9,14. Muscle
weakness may result in premature fatigue, reduced limb
loading and disuse. The reduced loading may interfere
with cartilage nutrition and lead to cartilage degenera-
tion36,37. Also, weakness of the quadriceps relative to the
hamstrings could have resulted in muscular imbalance
and loss of normal co-activation patterns which may haveFig. 5. Box plots showing the Mankin grades of the experimental and cont
the degenerative changes seen in the entire retro-patellar surface and the
to control group rabbits (*P< 0.05). Within each group, Mankin grades
different with the distal part most degenerated and thaltered normal joint mechanics and contact pressure distri-
bution38,39. Moreover, BTX-A-induced muscle weakness
might have affected sensory function that might have pre-
vented proper control of joint movement40,41. Also, weak
muscles are more susceptible to fatigue which, in turn,
could lead to reduced proprioceptive acuity42,43. Defective
quadriceps proprioception could result in inefﬁcient neuro-
muscular protection of the knee15,16. This might have re-
sulted in rapid loading and jarring of the knee and
subsequent microtrauma to the articular cartilage10,11.
The non-injected hind limbs of the experimental group
rabbits showed similar degenerative changes as those
seen in the BTX-A injected limbs. This ﬁnding might be
attributed to an increased or altered mechanical loading of
the non-injected limbs to compensate for the reduction in
muscle force on the experimental side, as observed
previously33,34,44,45.
The results of this study showed a location-dependent
degeneration of the retro-patellar cartilage. Experimental
and control group rabbits showed more severe signs of
OA in the distal and middle regions of the retro-patellarrol group rabbits. Mankin grades reﬂected a signiﬁcant difference in
distal 1/3 of the retro-patellar cartilage of the experimental compared
between the different regions of the retro-patellar cartilage were
e proximal part least degenerated (**P< 0.05).
Fig. 6. Sagittal section showing an example of retro-patellar cartilage from (left) an experimental BTX-A injected limb graded with a Mankin
grade of 8 and (right) its contra-lateral non-injected side graded as 5. Notice the more severe degenerative changes.
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dependent changes might be attributed to the different con-
tact mechanics in the distal and middle part of the patella
compared to the proximal region, or may be associated
with location-dependent differences in cartilage structure
and/or chondrocyte metabolic properties46. There were no
signiﬁcant differences in Mankin scores in the tibiofemoral
joints of experimental and control group rabbits.
It is not clear why difference between experimental and
control group animals was observed in the patellofemoral
but not the tibiofemoral joint. Degenerative changes of the
patellofemoral joint were reported to be the earliest changes
seen in humans47 and the most frequent chondral lesion
seen in adults48. For the current study, we speculate that
the degenerative changes in the retro-patellar cartilage
are associated with the fact that both the patella and quad-
riceps muscles are components of the knee extensor mech-
anism. The quadriceps muscles contribute to the stability
and the normal tracking of the patella in relation to the fem-
oral groove49. In the Botox-induced quadriceps weakness
model in the rabbit, the VL and rectus femoris were found
to be more atrophied than the vastus medialis33,34. This dif-
ference in muscle atrophy may have caused a muscle
strength imbalance in the knee extensor group and might
have resulted in maltracking of the patella and subsequent
changes in the retro-patellar pressure distribution50,51.
Thus, quadriceps weakness might have had a quicker
and a more obvious degenerative effect on the retro-patellar
cartilage compared to the tibiofemoral cartilage. Another ex-
planation for the increased degeneration of the retro-patel-
lar cartilage might be associated with location-dependent
structural differences of the articular cartilages in different
regions of the joint46,52. For example, retro-patellar cartilage
was found to be thicker and softer than the cartilage in the
femoral groove52e54. Observations of different macro- and
micro-structural properties of cartilages in joints have
been published in abundance54e58. Further studies are rec-
ommended to investigate and explain the location-depen-
dent changes seen in this Botox quadriceps muscle
weakness model.
The signiﬁcantly higher Mankin scores of the retro-patel-
lar cartilage found in the experimental compared to the con-
trol group rabbits suggest that quadriceps muscle
weakness might be an independent risk factor for knee
degeneration, and possibly OA in knee articular cartilage.
Extrapolation of the current results to other joints should
be made with caution. Knee stability is greatly inﬂuencedby musculature9,50. However, this is not necessarily true
for other joints, such as the hip, where the bony anatomy
provides good stability. How muscle weakness might affect
other joints, or knee joints in other species, needs further
elaboration.
A limitation of this study was that only one-time point fol-
lowing the creation of muscle weakness was evaluated.
Furthermore, this time point was relatively short (4 weeks),
and although degenerative changes in the rabbit knee are
known to occur quickly following ligament transection7, or
meniscectomy8, it would be important to follow this model
in the long-term and determine if it leads to bona ﬁde OA,
or if it merely represents a reversible change of knee
morphology.
Furthermore, the muscle weakness simulated in this ex-
perimental animal model was restricted to a single muscle
group: the knee extensors. Although such muscle weak-
ness can occur due to muscle or peripheral nerve injury,
it likely does not represent a large population. General
muscle weakness, affecting all or most limb muscles oc-
curs to a great extent in many sub-populations, for exam-
ple the elderly. Therefore, general muscle weakness, and
its effect on joint health, should be studied systematically
in the future. Muscle strength in the elderly might delay
the onset of idiopathic OA, or might slow its rate of pro-
gression. If so, strengthening exercises might provide
a low-cost, effective tool to preserve joint health in the
elderly and other populations affected by chronic muscle
weakness.
A third limitation of this study was the difﬁculty in inter-
preting whether the cartilage degeneration observed here
resulted directly from the imposed quadriceps muscle
weakness, or was merely a consequence of functional
changes as a result of the induced muscle weakness.
The causes for the degeneration in the retro-patellar car-
tilage of the BTX-A injected and the non-injected leg of
the experimental rabbits might be different: weakness as
a direct cause for the degeneration in the injected leg,
and compensation for the weakness in the non-injected
contra-lateral leg, but the result might be similar as ob-
served here. Nevertheless, the OA muscle weakness
model used here causes changes in the patellofemoral
joint that are quick and occur in the otherwise fully intact
joint. Moreover, in contrast to most other animal models,
the knees were permitted full active movement and there
was no direct interference with limb loading or joint
innervations.
1234 A. Rehan Youssef et al.: Weakness causes joint degenerationConclusion
Unilateral BTX-A-induced quadriceps weakness resulted
in increased Mankin scores of the retro-patellar cartilage but
not the tibiofemoral joint cartilage in experimental compared
to control group rabbits. This result provides evidence that
quadriceps weakness is a risk factor that, directly or through
its functional implications on joint loading, leads to the onset
and progression of osteoarthritic changes in the patellofe-
moral joint.
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